Reckitt's second wind: balanced growth returns even as the Gulf bites

Core Reckitt accelerates to +4.2% in Q2 on volumes and innovation, while a concrete Middle East supply shock replaces the tariff fixation gripping the rest of the market.

RKT.L · Earnings Call · 2026-07-29

The return of breadth

At first glance this was a modest print — Core Reckitt like-for-like net revenue grew 2.7% in H1 and adjusted EPS fell 9.7%. But the shape of the period tells the real story: after a weak Q1, the business accelerated sharply in Q2, with Core Reckitt up 4.2% and volumes up 2%, a genuinely balanced algorithm of volume, price and mix that has been the stated goal for two years. As Kris Licht put it, “we've delivered a significant acceleration across our business in the second quarter.” — Kris Licht, CEO · 2026-07-29 The most encouraging detail is how broad-based the acceleration was: all three geographic areas and all four categories improved sequentially in Q2. Emerging markets maintained high-single-digit growth (9.4% in the quarter), with China delivering a 12th consecutive quarter of double-digit growth on the back of Dettol Activ Botany and the VMS portfolio. That is the emerging markets engine management has been building toward since the 2024 strategy reset, and it is now genuinely broad — mix alone contributed 1.4 points in Q2. Licht stressed that consumers are still paying up for new news: “Meaningful innovation lands really well in the market and consumers are willing to pay a premium for it even in this environment.” — Kris Licht, CEO · 2026-07-29

The Middle East: from scenario to reality

The counterweight is the Gulf. While the global keyword slate this quarter is dominated by tariffs — with tariff refunds flagged across a swath of recent consumer-sector reporters — Reckitt barely mentions tariffs at all. Its exogenous cost shock is the Middle East, and it has shifted from a tail-risk scenario to an active operational cost. In the March call this was speculative; Kris Licht then said it was “too early for us to really assess where this is going.” — Kris Licht, Chief Executive Officer · 2026-03-05 Now it is concrete:

We have a plant in Bahrain that we actually had to close for the safety of our employees. And we have since reopened that, but it continues to be impacted certain days when there is a conflict and there is a danger, we closed the plant back down.
Kris Licht, CEO · 2026-07-29

The company is actively managing the input cost headwind — securing strategic inventories of solvents and plastics, shifting sourcing, and leaning on post-consumer recycled content. It is also using emerging-market pricing agility to blunt the blow, with Shannon Eisenhardt noting the benefit of being able to “take quick action around pricing in emerging markets as we saw the headwinds coming in from the crisis in the Middle East.” — Shannon Eisenhardt, CFO · 2026-07-29 Gross margin still fell 50 bps to 60.5%, and the group guides to a "significantly stronger" margin in the second half.

Innovation as the offset

The growth side of the ledger is being carried by innovation. Mucinex 12 Hour Cold & Fever, described by management as one of the most significant launches in recent years, began shipping at the end of Q2 and has already secured shelf facings of up to nine in some stores. That is the Mucinex 12-hour rollout teed up in prior calls and now in market — a large, seasonal, North-American profit pool. The company also opened its ninth global innovation hub in Shanghai to keep sourcing consumer insight from its strongest growth market. Not everything is healing. Europe remains the sore spot, down 3% in H1, with an especially promotional Auto Dish market. Management's position is a deliberate under-response: “We won't respond to every very deep promotional price point that we see in the marketplace. It just doesn't make sense.” — Kris Licht, CEO · 2026-07-29 They expect Europe to return to growth in H2 — but only modest growth.

What has genuinely changed

Three things stand out as new relative to prior calls. First, the Middle East has become an active operational drag rather than a hypothetical. Second, the Fuel for Growth program is now demonstrably offsetting the Essential Home stranded costs within the half, with fixed costs at 20.1% of net revenue and a target below 19% by end-2027. Recall Shannon's March guidance that Fuel for Growth would “largely offset those stranded costs... in 2026” — Shannon Eisenhardt, Chief Financial Officer · 2026-03-05 — that is now visible in the AOP margin of 23.6%, which came in ahead of expectations. Third, the North American destocking that haunted the seasonal OTC business appears to be over; management says inventories have been drawn down to levels where a sustained further pull is unlikely. The tape backdrop sharpens the contrast: while much of the consumer complex is busy capturing tariff-refund windfalls, Reckitt's currency of pain is the Middle East disruption, not trade policy. With another £500 million buyback, a 5% interim dividend increase, and guidance for 4–5% full-year growth reiterated, the market's question is whether the Gulf drag and Europe's promotional war can be outrun by emerging markets, Mucinex, and a Fuel for Growth program that is running ahead of plan. The second quarter — with its balanced, broad-based acceleration — is the first real evidence that the mix can work.